3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Gran Tierra stockholders approved the sale of the company's Colombian and Ecuadorian businesses to Maurel & Prom at a special meeting on October 9, 2026. The company expects about $315 million in net cash proceeds and targets closing on or about December 31, 2026, pending regulatory approvals in Colombia and Ecuador. Stockholders did not approve the non-binding advisory vote on compensation for named executive officers tied to the sale, with more votes against than for.
Sale approved: 19,351,115 shares for, 32,492 against, 7,328 abstaining, out of 19,390,935 shares represented at the meeting
Advisory vote on sale-related executive compensation: 9,557,007 for, 9,658,068 against, 175,860 abstaining
Expected net cash proceeds of about $315 million: about $250 million at closing and about $65 million 364 days later
Closing targeted on or about December 31, 2026, subject to regulatory approvals in Colombia and Ecuador; any share repurchase depends on completion of the sale
Cosmos Health reported preliminary, unaudited revenue of about $54.3 million for the nine months ended September 30, 2026, up 19% from $45.6 million a year earlier, and about $17.4 million for the third quarter. The company reaffirmed its expectation that full-year 2026 revenue will surpass $90 million, which matters to shareholders because it signals continued growth, though the figures are preliminary and the complete third-quarter results are not yet reported.
Nine-month 2026 revenue of about $54.3 million, up $8.7 million, or 19%, from $45.6 million in the same period of 2025
Third-quarter 2026 revenue of about $17.4 million, compared with a record $17.1 million in the third quarter of 2025
Full-year 2026 revenue outlook of over $90 million reaffirmed; the company expects the fourth quarter to be its strongest ever
Figures are preliminary and unaudited; complete third-quarter results will be reported in the Form 10-Q
Avalanche Treasury Corp received a letter from Nasdaq on October 7, 2026, stating it has regained compliance with the $1.00 minimum bid price requirement for its Class A common stock. Nasdaq closed the matter after the stock's closing bid price was at or above $1.00 for 13 consecutive business days. The notice removes a listing deficiency that had been pending since August 6, 2026.
Nasdaq notified the company on August 6, 2026 that its Class A stock had closed below $1.00 for 33 consecutive business days
On October 7, 2026, Nasdaq confirmed the stock closed at $1.00 or above for 13 consecutive business days, from September 18 to October 6, 2026
Nasdaq determined the company regained compliance and closed the matter
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.